SBN 0.00% 0.0¢ sun biomedical limited

latest announcement, page-8

  1. 3,680 Posts.
    lightbulb Created with Sketch. 567
    One thing that concerns me is that the new executive directors haven't much skin in the game. I would think they'd buy on market. H Digby dropped $20k into Cynata late last year:

    http://www.asx.com.au/asxpdf/20131219/pdf/42lqbmq1jsgb2d.pdf

    IMO buying on-market SBN would make a hell of a difference, not because it would move the price but because it would assure shareholders that directors believe in the company.
 
watchlist Created with Sketch. Add SBN (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.